Markets:

Overview

News

Currencies

International

Treasuries

Invivyd, Inc. - Common Stock (NQ:IVVD)

0.9276 -0.0062 (-0.66%)

Streaming Delayed Price Updated: 2:07 PM EDT, Jun 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Invivyd, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Why Stoke Therapeutics Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket ↗

March 26, 2024

Shares of Stoke Therapeutics, Inc. (NASDAQ: STOK) rose sharply in today’s pre-market trading after the company announced Phase 1/2a data supporting the potential for STK-001

Via Benzinga

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 25, 2024

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

Via Benzinga

Recap: Invivyd Q3 Earnings ↗

November 09, 2023

Via Benzinga

Invivyd's Earnings: A Preview ↗

November 08, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 25, 2024

Via Benzinga

Aehr Test Systems Reports Preliminary Results, Joins Dyne Therapeutics, United Airlines And Other Big Stocks Moving Lower On Monday ↗

March 25, 2024

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Monday.

Via Benzinga

Topics Stocks

FDA Gives Emergency Use Nod To Invivyd's Antibody To Prevent COVID-19 Infection In Adults, Adolescents With Weak Immune System ↗

March 25, 2024

FDA grants emergency use authorization to Invivyd's Pemgarda (pemivibart), a monoclonal antibody for COVID-19 prevention in immune-compromised adults. Interim trial data revealed.

Via Benzinga

Why Salarius Pharmaceuticals Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket ↗

March 25, 2024

Shares of Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) rose sharply in today’s pre-market trading following fourth-quarter results.

Via Benzinga

Invivyd Announces Interim Exploratory Data on VYD222 from Ongoing CANOPY Clinical Trial

March 22, 2024

From Invivyd

Via GlobeNewswire

Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19

March 22, 2024

From Invivyd

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

February 12, 2024

Via Benzinga

Why Big Lots Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

February 12, 2024

Shares of Big Lots, Inc. (NYSE: BIG) fell sharply during Monday’s session after the company reported preliminary fourth-quarter results. Also, Loop Capital downgraded the stock from Hold to Sell and...

Via Benzinga

Invivyd to Participate at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

February 05, 2024

From Invivyd

Via GlobeNewswire

3 Groundbreaking Biotech Stocks to Invest in Now ↗

January 29, 2024

These are several biotech companies for investors seeking unique opportunities for great returns within the industry.

Via InvestorPlace

Apple To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Thursday ↗

January 18, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

January 10, 2024

The biggest pre-market stock movers for Wednesday are ready to go as we break down all of the latest news moving shares today!

Via InvestorPlace

Invivyd Submits Request for Emergency Use Authorization (EUA) to U.S. FDA for VYD222 for the Pre-exposure Prevention of COVID-19 in Immunocompromised Adults and Adolescents

January 03, 2024

From Invivyd

Via GlobeNewswire

Invivyd Stock More Than Doubled Last Week. Is It Too Late to Buy? ↗

December 23, 2023

The clinical-stage biotech delivered positive trial results for its new COVID-19 preventative antibody treatment.

Via The Motley Fool

Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

December 19, 2023

Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy...

Via Benzinga

Bluebird Bio, Vertex Energy And Other Big Stocks Moving Lower On Tuesday ↗

December 19, 2023

U.S. stocks traded higher, with the Dow Jones index gaining around 150 points on Tuesday. Shares of bluebird bio, Inc. (NASDAQ: BLUE) shares fell sharply during Tuesday’s session after the company...

Via Benzinga

Topics Stocks

Nasdaq Gains 100 Points; Biomerica Shares Spike Higher ↗

December 18, 2023

U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining over 100 points on Monday. The Dow traded up 0.01% to 37,307.40 while the NASDAQ rose 0.71% to 14,919.07....

Via Benzinga

Topics Stocks

Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

December 18, 2023

Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 18, 2023

Via Benzinga

Crude Oil Rises 3%; US Housing Market Index Increases In December ↗

December 18, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 50 points on Monday. The Dow traded up 0.14% to 37,356.29 while the NASDAQ rose 0.25% to 14,851.19. The S&P 500...

Via Benzinga

Topics Stocks

Why Is COVID-19 Antibody Focused Invivyd Stock Trading Over 150% Higher Today? ↗

December 18, 2023

Invivyd Inc (NASDAQ: IVVD) shares are trading higher after the company released initial results from the ongoing CANOPY Phase 3 pivotal clinical trial of VYD222, a broadly neutralizing, half-life...

Via Benzinga

Invivyd Announces Positive Initial Results from Ongoing CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of COVID-19

December 18, 2023

From Invivyd

Via GlobeNewswire

Invivyd Reports Third Quarter 2023 Financial Results and Recent Business Highlights

November 09, 2023

From Invivyd

Via GlobeNewswire

Invivyd to Host Conference Call Discussing Third Quarter 2023 Financial Results and Business Highlights

November 02, 2023

From Invivyd

Via GlobeNewswire

Invivyd to Participate in Upcoming Investor Conferences

October 31, 2023

From Invivyd

Via GlobeNewswire

Invivyd Announces Dosing of First Participant in CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of Symptomatic COVID-19

September 11, 2023

Initial primary endpoint data anticipated in late 2023 or early Q1 2024

From Invivyd

Via GlobeNewswire

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.